Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes. Its Saphyr system includes an instrument, chip consumables, reagents, a suite of data analysis tools, and genome analysis services for researchers to evaluate optical genome mapping data. The company’s Bionano prep kits and labeling kits provide the reagents and protocols needed to extract and label ultra-high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for Bionano Genomics, Inc. (BNGO)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
a week ago | InvestorPlace
a week ago | Zacks Investment Research
a week ago | GlobeNewsWire
a week ago | InvestorPlace
2 weeks ago | Zacks Investment Research
2 weeks ago | GlobeNewsWire
2 weeks ago | Zacks Investment Research
3 weeks ago | InvestorPlace
a month ago | InvestorPlace